Accumulating evidence has suggested that aberrant expression of FOXM1 contributes to the carcinogenesis and progression of pancreatic cancer (Cui et al., 2016; Quan et al., 2013). The gene discussed is FOXM1; the disease is familial pancreatic carcinoma.